Memantine: Memantine is FDA-approved for moderate-to-severe Alzheimer's disease at therapeutic doses of 5-20 mg daily. Recreational use is rare due to extremely long duration (18-36+ hours with residual effects up to 72 hours) and slow onset. The 60-80 hour half-life causes multi-day accumulation; d
Related pages